| Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models M Bergstrand, AC Hooker, JE Wallin, MO Karlsson The AAPS journal 13, 143-151, 2011 | 1286 | 2011 |
| Handling data below the limit of quantification in mixed effect models M Bergstrand, MO Karlsson The AAPS journal 11, 371-380, 2009 | 354 | 2009 |
| PBPK models for the prediction of in vivo performance of oral dosage forms ES Kostewicz, L Aarons, M Bergstrand, MB Bolger, A Galetin, O Hatley, ... European Journal of Pharmaceutical Sciences 57, 300-321, 2014 | 330 | 2014 |
| Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resampling AG Dosne, M Bergstrand, K Harling, MO Karlsson Journal of pharmacokinetics and pharmacodynamics 43, 583-596, 2016 | 221 | 2016 |
| An automated sampling importance resampling procedure for estimating parameter uncertainty AG Dosne, M Bergstrand, MO Karlsson Journal of pharmacokinetics and pharmacodynamics 44, 509-520, 2017 | 109 | 2017 |
| Population pharmacokinetics of busulfan in children: increased evidence for body surface area and allometric body weight dosing of busulfan in children MN Trame, M Bergstrand, MO Karlsson, J Boos, G Hempel Clinical Cancer Research 17 (21), 6867-6877, 2011 | 73 | 2011 |
| Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models C Vong, M Bergstrand, J Nyberg, MO Karlsson The AAPS journal 14, 176-186, 2012 | 71 | 2012 |
| Comparisons of analysis methods for proof‐of‐concept trials KE Karlsson, C Vong, M Bergstrand, EN Jonsson, MO Karlsson CPT: pharmacometrics & systems pharmacology 2 (1), 1-8, 2013 | 62 | 2013 |
| Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy J Tarning, P Chotsiri, V Jullien, MJ Rijken, M Bergstrand, M Cammas, ... Antimicrobial agents and chemotherapy 56 (11), 5764-5773, 2012 | 52 | 2012 |
| Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance JE Wallin, M Bergstrand, HE Wilczek, PS Nydert, MO Karlsson, CE Staatz Therapeutic drug monitoring 33 (6), 663-672, 2011 | 48 | 2011 |
| Mechanistic Modeling of a Magnetic Marker Monitoring Study Linking Gastrointestinal Tablet Transit, In Vivo Drug Release, and Pharmacokinetics M Bergstrand, E Söderlind, W Weitschies, MO Karlsson CliniCal pharmaCology & TherapeuTiCs 86 (1), 77-83, 2009 | 46 | 2009 |
| A mechanism-based approach for absorption modeling: the Gastro-Intestinal Transit Time (GITT) model E Hénin, M Bergstrand, JF Standing, MO Karlsson The AAPS journal 14, 155-163, 2012 | 35 | 2012 |
| A strategy for residual error modeling incorporating scedasticity of variance and distribution shape AG Dosne, M Bergstrand, MO Karlsson Journal of Pharmacokinetics and Pharmacodynamics 43, 137-151, 2016 | 31 | 2016 |
| Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention M Bergstrand, F Nosten, KM Lwin, MO Karlsson, NJ White, J Tarning Science translational medicine 6 (260), 260ra147-260ra147, 2014 | 26 | 2014 |
| Meta-analysis of magnetic marker monitoring data to characterize the movement of single unit dosage forms though the gastrointestinal tract under fed and fasting conditions E Hénin, M Bergstrand, W Weitschies, MO Karlsson Pharmaceutical research 33, 751-762, 2016 | 24 | 2016 |
| A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations M Bergstrand, E Söderlind, UG Eriksson, W Weitschies, MO Karlsson Pharmaceutical research 29, 695-706, 2012 | 23 | 2012 |
| Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine J Permala, J Tarning, F Nosten, NJ White, MO Karlsson, M Bergstrand Antimicrobial agents and chemotherapy 61 (5), 10.1128/aac. 02491-16, 2017 | 21 | 2017 |
| Prediction corrected visual predictive checks M Bergstrand, AC Hooker, JE Wallin, MO Karlsson American Conference on Pharmacometrics, 2009 | 20 | 2009 |
| Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar JP Lohy Das, MP Kyaw, MH Nyunt, K Chit, KH Aye, MM Aye, MO Karlsson, ... Malaria Journal 17, 1-10, 2018 | 19 | 2018 |
| A semi-mechanistic modeling strategy for characterization of regional absorption properties and prospective prediction of plasma concentrations following administration of new … M Bergstrand, E Söderlind, UG Eriksson, W Weitschies, MO Karlsson Pharmaceutical research 29, 574-584, 2012 | 19 | 2012 |
Mats KarlssonUppsala UniversityVerified email at farmaci.uu.se
